Johnson & Johnson (
) will begin trading ex-dividend on May 23, 2013. A cash dividend
payment of $0.66 per share is scheduled to be paid on June 11,
2013. Shareholders who purchased JNJ stock prior to the ex-dividend
date are eligible for the cash dividend payment. This represents an
8.2% increase over the prior quarter. At the current stock price of
$88.59, the dividend yield is 2.98%.
The previous trading day's last sale of JNJ was $88.59,
representing a -0.06% decrease from the 52 week high of $88.64 and
a 43.56% increase over the 52 week low of $61.71.
JNJ is a part of the Consumer Durables sector, which includes
companies such as Pfizer, Inc. (
) and Novartis AG (
). JNJ's current earnings per share, an indicator of a company's
profitability, is $3.68. Zacks Investment Research reports JNJ's
forecasted earnings growth in 2013 as 6.2%, compared to an industry
average of -3.4%.
For more information on the declaration, record and payment
dates, visit the
Interested in gaining exposure to JNJ through an Exchange
Traded Fund [ETF]?
The following ETF(s) have JNJ as a top-10 holding:
- iShares Dow Jones U.S. Pharmaceutical Index Fund (
- Select Sector SPDR Fund - Health Care (
- iShares Dow Jones U.S. Health Care Index Fund (
- Merrill Lynch Pharmaceutical HOLDRS (
- Vanguard Health Care ETF (
The top-performing ETF of this group is IYH with an increase of
23.92% over the last 100 days. IHE has the highest percent
weighting of JNJ at 9.94%.